Swift Biosciences Launches Next Phase of Company Growth and Expansion
Company completes Series D funding and adds two new directors to board (ANN ARBOR, Mich. – June 29, 2017) Swift Biosciences, a leading provider of innovative library prep solutions for genomic sequencing, today announced the completion of a Series D funding raise of $12.2 million. The company also announced the addition of two new directors to... Read more